Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature

被引：2
|
作者：
Gautret, Philippe [1 ,2 ]
Van Thuan Hoang [1 ,2 ,3 ]
Honore, Stephane [4 ,5 ]
Roussel, Yanis [1 ,6 ]
Million, Matthieu [1 ,6 ]
Lagier, Jean-Christophe [1 ,6 ]
Raoult, Didier [1 ,6 ]
机构：
[1] IHU Mediterranee Infect, Marseille, France
[2] Aix Marseille Univ, IRD, AP HM, SSA,VITROME, Marseille, France
[3] Thai Binh Univ Med & Pharm, Thai Binh, Vietnam
[4] Hop La Timone, AP HM, Serv Pharm, Marseille, France
[5] Aix Marseille Univ, Lab Pharmacie Clin, Marseille, France
[6] Aix Marseille Univ, IRD, APHM, MEPHI, Marseille, France
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2021年 / 57卷 / 01期
关键词：
D O I：
10.1016/j.ijantimicag.2020.106241
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [21] Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated With Hydroxychloroquine and/or Azithromycin
    Chang, David
    Saleh, Moussa
    Gabriels, James
    Ismail, Haisam
    Goldner, Bruce
    Willner, Jonathan
    Beldner, Stuart
    Mitra, Raman
    John, Roy
    Epstein, Laurence M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (23) : 2992 - 2993
  • [22] Hydroxychloroquine alone or in combination with azithromycin and corrected QT prolongation in COVID-19 patients: A systematic review
    Haleh Ashraf
    Parham Ghafouri
    Sina Kazemian
    Abbas Soleimani
    Azadeh Sadat Naseri
    Shahrokh Karbalai
    Ali Kazemi Saeid
    World Journal of Meta-Analysis, 2021, 9 (06) : 557 - 567
  • [23] Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen
    Bernardini, Andrea
    Ciconte, Giuseppe
    Negro, Gabriele
    Rondine, Roberto
    Mecarocci, Valerio
    Viva, Tommaso
    Santini, Francesca
    de Innocentiis, Carlo
    Giannelli, Luigi
    Witkowska, Ewa
    Locati, Emanuela Teresina
    Castelvecchio, Serenella
    Marrocco-Trischitta, Massimiliano M.
    Vicedomini, Gabriele
    Menicanti, Lorenzo
    Pappone, Carlo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 324 : 242 - 248
  • [24] Ventricular Arrhythmia Risk Based on Ethnicity in COVID-19 Patients on Hydroxychloroquine and Azithromycin Combination: Viewpoint
    Sayak Roy
    SN Comprehensive Clinical Medicine, 2020, 2 (8) : 1019 - 1024
  • [25] Hydroxychloroquine with or without Azithromycin in Covid-19 REPLY
    Cavalcanti, Alexandre B.
    Berwanger, Otavio
    Zampieri, Fernando G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (02): : 191 - 191
  • [26] Hydroxychloroquine and Azithromycin Combination in the Management of COVID-19 Infection: Safety and Effectiveness Challenges
    Abou Warda, Ahmed E.
    Tammam, Mahmoud
    El-Gazar, Rabab A.
    Sarhan, Rania M.
    Gaber, Sayed
    CURRENT DRUG SAFETY, 2022, 17 (02) : 143 - 151
  • [27] COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients
    Stewart, Mark
    Rodriguez-Watson, Carla
    Albayrak, Adem
    Asubonteng, Julius
    Belli, Andrew
    Brown, Thomas
    Cho, Kelly
    Das, Ritankar
    Eldridge, Elizabeth
    Gatto, Nicolle
    Gelman, Alice
    Gerlovin, Hanna
    Goldberg, Stuart L.
    Hansen, Eric
    Hirsch, Jonathan
    Ho, Yuk-Lam
    Ip, Andrew
    Izano, Monika
    Jones, Jason
    Justice, Amy C.
    Klesh, Reyna
    Kuranz, Seth
    Lam, Carson
    Mao, Qingqing
    Mataraso, Samson
    Mera, Robertino
    Posner, Daniel C.
    Rassen, Jeremy A.
    Siefkas, Anna
    Schrag, Andrew
    Tourassi, Georgia
    Weckstein, Andrew
    Wolf, Frank
    Bhat, Amar
    Winckler, Susan
    Sigal, Ellen, V
    Allen, Jeff
    PLOS ONE, 2021, 16 (03):
  • [28] Repolarization Vulnerability is Rarely Observed in COVID-19 Patients With Low Comorbidity Treated With a Combination of Hydroxychloroquine Azithromycin
    Goldgrab, David E.
    Kalaveshi, Sokol
    Yang, Ruifang
    Gomez, Mauricio
    Craig, Jearim
    Mester, Stephen
    Perzanowski, Christian
    CIRCULATION, 2020, 142
  • [29] Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes?
    Megarbane, Bruno
    Scherrmann, Jean-Michel
    JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 60 (07): : 808 - 814
  • [30] Re: effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: author's response
    Fiolet, Thibault
    Guihur, Anthony
    Rebeaud, Mathieu Edouard
    Mulot, Matthieu
    Peiffer-Smadja, Nathan
    Mahamat-Saleh, Yahya
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (06) : 920 - 921
12345